Literature DB >> 20555289

Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk.

Lisa Langsetmo1, Suzanne Morin, Christopher S Kovacs, Nancy Kreiger, Robert Josse, Jonathan D Adachi, Alexandra Papaioannou, David Goltzman, David A Hanley, Wojciech P Olszynski, Jerilynn Prior, Sophie A Jamal.   

Abstract

OBJECTIVE: Most low-trauma fractures occur among women with osteopenic bone mineral density (BMD), a population considered to have moderate absolute fracture risk. Our purpose was to refine the fracture risk prediction in women with osteopenic BMD to determine the subgroups at lowest and highest risk.
METHODS: We included 2,588 women aged 50 to 90 years with osteopenic BMD (femoral neck BMD between -1 and -2.5) participating in the Canadian Multicentre Osteoporosis Study, an ongoing prospective cohort study of randomly selected Canadians. Baseline variables, in addition to known risk factors, age, and BMD, were considered for inclusion in a model for the prediction of 5-year absolute risk of low-trauma fracture. Models were derived using logistic regression and assessed by the Bayesian Information Criterion.
RESULTS: We found an increased fracture risk among those with lower BMD (odds ratio [OR], 1.53; 95% CI, 1.06-2.21) for each decrease in femoral neck T score (eg, from -1 to -2), those with prior low-trauma fracture (OR, 2.06; 95% CI, 1.46-2.92), those with self-reported worse general health (OR, 1.35; 95% CI, 1.15-1.59) for each lower category (categories: excellent, very good, good, fair, poor), and those with height loss (OR, 1.44; 95% CI, 1.16-1.90) for each 5-cm difference between current and maximal height. The new model had yielded a better risk stratification than did a model with World Health Organization risk factors.
CONCLUSIONS: Including risk factors such as general health and height loss can be used to provide a highly effective assessment of fracture risk among women with osteopenic BMD.

Entities:  

Mesh:

Year:  2010        PMID: 20555289      PMCID: PMC4498900          DOI: 10.1097/gme.0b013e3181da4b7d

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  23 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  A Tenenhouse; L Joseph; N Kreiger; S Poliquin; T M Murray; L Blondeau; C Berger; D A Hanley; J C Prior
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

3.  Identification of osteopenic women at high risk of fracture: the OFELY study.

Authors:  Elisabeth Sornay-Rendu; Françoise Munoz; Patrick Garnero; François Duboeuf; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2005-06-20       Impact factor: 6.741

4.  Risk of new vertebral fracture in the year following a fracture.

Authors:  R Lindsay; S L Silverman; C Cooper; D A Hanley; I Barton; S B Broy; A Licata; L Benhamou; P Geusens; K Flowers; H Stracke; E Seeman
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

5.  Risk factors for fracture in nonosteoporotic men and women.

Authors:  Nguyen D Nguyen; John A Eisman; Jacqueline R Center; Tuan V Nguyen
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

6.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

7.  An approach to identifying osteopenic women at increased short-term risk of fracture.

Authors:  Paul D Miller; Suna Barlas; Susan K Brenneman; Thomas A Abbott; Ya-Ting Chen; Elizabeth Barrett-Connor; Ethel S Siris
Journal:  Arch Intern Med       Date:  2004-05-24

8.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

9.  Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.

Authors:  Claudie Berger; Lisa Langsetmo; Lawrence Joseph; David A Hanley; K Shawn Davison; Robert Josse; Nancy Kreiger; Alan Tenenhouse; David Goltzman
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

10.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.

Authors:  N D Nguyen; S A Frost; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2008-03-07       Impact factor: 4.507

View more
  3 in total

1.  Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial.

Authors:  Carolyn J Crandall; Aaron K Aragaki; Meryl S LeBoff; Wenjun Li; Jean Wactawski-Wende; Jane A Cauley; Karen L Margolis; JoAnn E Manson
Journal:  Menopause       Date:  2016-12       Impact factor: 2.953

Review 2.  Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.

Authors:  Carolyn J Crandall
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

3.  Osteopenia due to enhanced cathepsin K release by BK channel ablation in osteoclasts.

Authors:  Ulrike Sausbier; Christian Dullin; Jeannine Missbach-Guentner; Clement Kabagema; Katarina Flockerzie; Gerd Marten Kuscher; Walter Stuehmer; Winfried Neuhuber; Peter Ruth; Frauke Alves; Matthias Sausbier
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.